One therapy to tackle both anxiety and drinking in veterans?
NCT ID NCT04871100
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a single cognitive behavioral therapy (CBT) program designed to help veterans who struggle with both anxiety (including PTSD) and hazardous drinking. The goal is to see if treating both issues together improves their daily functioning and reduces symptoms better than usual care. Forty veterans will participate, and the study measures changes in anxiety, alcohol use, and social adjustment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cognitive behavioral therapy (CBT) program that addresses anxiety, PTSD, and alcohol use together
- What this could lead to
- If successful, this could provide an effective single therapy that helps veterans manage both anxiety and alcohol use, improving their social and occupational functioning.
- What could go wrong
- This is a small early-stage study with only 40 participants, so results may not apply broadly. The therapy requires weekly sessions, and not everyone may benefit or complete the program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2023
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * meeting diagnostic criteria for current anxiety disorder and * endorsing hazardous alcohol use Exclusion Criteria: -need for acute medically-supervised detoxification with exclusionary criteria of * high-risk suicidality * psychotic symptoms, or * cognitive impairment that could interfere with engagement in weekly psychotherapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI decode how trauma therapy heals?
- Can a Two-Day couples retreat ease PTSD?
- Can community health workers help trauma survivors heal?
- Can a blood pressure drug rewrite trauma memories to ease fibromyalgia?
- Can adding social support to trauma therapy ease PTSD in youth?
- Can ketamine rewire fear memories to ease PTSD?